Skip to main content

Table 4 Comparison of the treatment and outcome of patients with pulmonary cryptococcosis, according to eGFR

From: Clinical impact of advanced chronic kidney disease in patients with non-HIV pulmonary cryptococcosis

 

eGFR > 45

eGFR ≤45

p value

No treatment

3 (7.1%)

2 (14.3%)

0.44

Treatment

 Antifungal drugs

34/39 (87.2%)

12/12 (100%)

0.09

 Treatment duration (months) a

8.9 ± 1.7

11.0 ± 2.8

0.53

 Surgery

5/39 (12.8%)

0/12 (0.0%)

0.09

Outcome

 Recovered*

37/40 (92.5%)

7/11 (63.6%)

0.02

  1. eGFR estimated glomerular filtration rate
  2. *2 patients with eGFR > 45 and 3 patients with eGFR ≤45 were not evaluated because of no information about the outcome
  3. a Data are presented as mean ± standard deviation